Rapid Infusion of Cold Normal Saline During CPR for Patients With Out-of-hospital Cardiac Arrest

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

That paramedic core cooling during CPR using a rapid infusion of ice-cold (4 degrees C) large-volume (30mL/kg) normal saline improves outcome at hospital discharge compared with standard care in patients with out-of-hospital cardiac arrest.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation

NCT03133767

Fluid Loss Symptom Complex, Triple Emergencies

COMPLETED PHASE4

Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury

NCT00113685

Respiratory Distress Syndrome, Adult Head Injuries, Closed Shock +1 more

COMPLETED NA

Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered Evaluation

NCT00885404

Shock Critical Illness

UNKNOWN PHASE4

Effect of Fluid Resuscitation on Lactate in Traumatic Injury Patients

NCT06370975

Fluid Resuscitation

NOT_YET_RECRUITING PHASE1/PHASE2

AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA

NCT03191240

Out-of-Hospital Cardiac Arrest

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

INTRODUCTION:

Pre-hospital cardiac arrest is common and associated with a poor prognosis and only about 8% of patients have a good outcome. For patients who are initially successfully resuscitated by ambulance paramedics and transported to hospital, there is considerable mortality and morbidity. This is largely due to the anoxic brain injury sustained during the cardiac arrest.

One current therapy for the severe anoxic brain injury following out-of-hospital cardiac arrest is therapeutic hypothermia (TH) induced after resuscitation. This treatment was shown to improve outcomes in two clinical trials. The International Liaison Committee on Resuscitation now recommend TH (33°C for 12-24 hours) for patients who remain comatose after resuscitation from cardiac arrest.

However, the optimal timing of TH is still uncertain. The above clinical studies used surface cooling and this delayed TH until after arrival at the hospital. On the other hand, laboratory data has suggested that there is significantly decreased neurological injury if cooling is initiated during CPR.

The current ideal technique for induction of TH during CPR is a rapid intravenous infusion of a large volume of ice-cold fluid. This technique has become established as the cooling method of choice in the pre-hospital setting, the Emergency Department (14) and the Intensive Care Unit.

Previously, we conducted a randomised, controlled trial of paramedic cooling after CPR compared with cooling in the emergency department (ED) (NHMRC study number 236879). This study enrolled 396 patients between 2005 and late 2007. There were 234 patients with an initial cardiac rhythm of ventricular fibrillation (VF) and 163 patients with an initial cardiac rhythm of non-VF (asystole or pulseless electrical activity).

In the post-VF arrest patients, there was a good outcome (discharge to home or to rehabilitation) in both groups of 50%. In the post-non-VF arrest patients, there was a good outcome at hospital discharge of 12% in the paramedic cooled group compared with 9% in the standard care group. The study was stopped at the interim analysis due to a lack of difference in the primary outcome measure (outcome at hospital discharge) between the two groups (futility).

Further analysis of this data revealed that paramedics infused up to 1000mL ambient temperature fluid during CPR prior to enrolment as part of standard paramedic treatment. In addition, the rapid infusion of cold fluid was commenced en-route to hospital. Thus, cooling commenced approximately 30 minutes after paramedic arrival and only just prior to hospital cooling. Although there was a decrease in the core temperatures of the patients allocated to pre-hospital cooling on arrival at the ED, this was a transient effect lasting only approximately 20 minutes. Subsequently, the cooling curves of the patients in both groups were identical. Thus, it was considered unlikely that this transient difference in core temperature could have a measurable effect on outcomes.

Laboratory data suggests that a rapid intravenous infusion of cold fluid during CPR effectively decreases core temperature. Nordmark et al. studied the induction of hypothermia with a large volume of intravenous ice-cold fluid after cardiac arrest during CPR in anaesthetised piglets who were subjected to eight minutes of VF. The mean temperature reduction was 1.6°C in the hypothermic group and 1.1°C in the control group (p=0.009).

There is also laboratory data that cooling during CPR may increase the rate of successful defibrillation. Boddicker et al. examined the success rates of defibrillation in swine cooled to different temperatures. After 8 minutes of VF (with no CPR), the animals were defibrillated with successive shocks as needed and underwent CPR until resumption of spontaneous circulation or no response. First-shock defibrillation success was highest in the hypothermia (33°C) group (6/8 hypothermia versus 1/8 normothermia; P=0.04). None of the 8 animals in the normothermia group achieved resumption of spontaneous circulation compared with 7/8 moderate hypothermia (P=0.001). Coronary perfusion pressure during CPR was not different between the groups, thus this beneficial effect of hypothermia was not due to alteration of coronary perfusion pressure but likely due to changes in the electrophysiological properties of the myocardium. Thus, it appears that mild hypothermia may have a beneficial anti-arrhythmic effect, as well as a neuroprotective effect.

More recently, pilot clinical trials have been undertaken in Europe that suggest that cooling during CPR by paramedics is feasible. For example, Bruel et al studied the feasibility and safety of a rapid infusion of 2000mL of normal saline at 4°C during CPR. A total of 33 patients were included in the study of whom eight patients presented with VF as the initial cardiac rhythm. After intravenous cooling, the temperature in the patients decreased by a mean of 2.1°C.

In a similar pilot study, Kämäräinen et al. cooled seventeen adult patients with out-of-hospital cardiac arrest during CPR. A return of circulation was achieved in 13 patients (76%). The temperature of the patients on hospital admission was a mean of 33.8°C and the mean infused volume of cold fluid was 1571mL. The authors concluded that induction of therapeutic hypothermia during prehospital CPR was feasible and apparently well tolerated.

More recent data specifically examining respiratory function in 52 patients treated with large volume, ice cold saline has indicated that there is no adverse effect on respiratory function.

Given this supportive laboratory and preliminary clinical data, and our previous experience in running a large pre-hospital trial in cardiac arrest patients, we propose to conduct a definitive randomized, controlled trial of paramedic cooling during CPR compared with standard care including cooling after arrival at the hospital.

In the treatment arm, paramedics will undertake immediate cooling during cardiac arrest, using a large volume (20mL/kg, followed by 10mL/kg) intravenous bolus of ice-cold saline. This strategy will overcome the delay in treatment that was found in our previous study. Thus, cooling will commence significantly earlier, possibly resulting in significantly improved rates of resuscitation and better neurological outcomes.

In the control arm, patients will be resuscitated using current protocols and be cooled after arrival at the hospital (the current standard of care).

The trial will run as two parallel clinical trials because of the marked difference in outcomes between patients with VF as the initial cardiac rhythm and patients with non-VF as the initial cardiac rhythm.

STUDY DETAILS

HYPOTHESIS:

That paramedic core cooling during CPR using a rapid infusion of ice-cold (4 degrees C) large volume (30mL/kg total) normal saline improves outcome at hospital discharge compared with standard care in patients with out-of-hospital cardiac arrest.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Out-of-hospital Cardiac Arrest

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Treatment

For patients randomised to hospital cooling:

* LMA/ Intubation and ventilation with 100% oxygen
* Measure temperature using tympanic probe and record
* Insert IV line and administer drugs as per protocol
* Fluid challenge with standard temperature saline only as per current guideline (suspected hypovolemia)
* Post resuscitation: midazolam 1-5 mg only to maintain LMA/ intubation as needed.
* Pancuronium 8 mg only if intubation unable to be maintained with midazolam.

After arrival at the Emergency Department, all patients receive standard care.

Group Type NO_INTERVENTION

PARAMEDIC COOLING

Intervention Type PROCEDURE

For patients randomised to paramedic cooling:

* LMA/ Intubation and ventilation with 100% oxygen
* Measure temperature using tympanic probe and record
* Paramedic cooling using infusion of 20mL/kg cold fluid via IV during CPR
* If temperature \>34.5ºC, infuse further 10mL/kg stat
* After ROSC, infuse further (max 2 litres) ice-cold saline
* If shivering occurs post resuscitation and intubated, administer midazolam 2-5mg IV and pancuronium 8 mg.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PARAMEDIC COOLING

For patients randomised to paramedic cooling:

* LMA/ Intubation and ventilation with 100% oxygen
* Measure temperature using tympanic probe and record
* Paramedic cooling using infusion of 20mL/kg cold fluid via IV during CPR
* If temperature \>34.5ºC, infuse further 10mL/kg stat
* After ROSC, infuse further (max 2 litres) ice-cold saline
* If shivering occurs post resuscitation and intubated, administer midazolam 2-5mg IV and pancuronium 8 mg.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Intervention arm

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Are adults \> 18 years/ are in cardiac arrest (pulseless) on arrival of paramedics

Exclusion Criteria

In cardiac arrest following trauma or suspected intra-cranial bleeding/ obviously pregnant/ Dependant on others for activities of daily living (ie any assistance with activities of daily living, in supported care or nursing home residents) or have pre-existing significant neurological injury,Likely to be "Not for Resuscitation" and/or admission to the Intensive Care Unit because of terminal disease or advanced age, Patients who are hypothermic already and are confirmed to be on temperature measurement/ in-hospital cardiac arrest.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No